Next-generation Sequencing Informatics Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Products and Services (NGS Informatics Services, Data Analysis and Management Tool, Primary and Secondary Data Analysis Tools); Application (Drug Discovery, Genetic Screening, Diseases Diagnosis, Precision Medicine, Other Applications); End User (Hospitals and Clinics, Academics and Research Institutes, Pharmaceuticals Companies) and Geography
Report Code: TIPRE00006921 No. of Pages: 151 Category: Healthcare IT Status: Upcoming
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION
Next-generation DNA sequencing (NGS) technology is widely used in a variety of research applications like gene expression, metagenomics, epigenetics, and others. DNA sequencing generates a large volume of data, and analyzing such data can be tedious. Next-generation sequencing informatics tools smooth the process of analyzing sequencing data, thus allowing the scientists to spend more time on research and less time configuring workflows.
MARKET DYNAMICS
The next generation sequencing informatics market is anticipated to grow in the forecast growing adoption of NGS in research and development, constant innovation and developments in the NGS technology and rising demand for tools required for analyzing sequencing data. In addition, untapped market opportunities in emerging nations is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Next generation sequencing informatics market Analysis to 2028" is a specialized and in-depth study of the Healthcare IT industry with a special focus on the global market trend analysis. The report aims to provide an overview of next generation sequencing informatics market with detailed market segmentation by product and services, application, and end user and geography. The next generation sequencing informatics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading next generation sequencing informatics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The next generation sequencing informatics market is segmented on the basis of product and services, application and end user. Based on product and services the market is segmented as NGS informatics services, data analysis & management tool, and primary & secondary data analysis tools. The application segment is divided into drug discovery, genetic screening, diseases diagnosis, precision medicine, and other applications. The technique market is divided into epicardial pacing, transvenous pacing, and transcutaneous pacing. On the basis of end user the market is segmented into hospitals and clinics, academics and research institutes, and pharmaceuticals companies.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the next generation sequencing informatics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The next generation sequencing informatics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting next generation sequencing informatics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the next generation sequencing informatics market in these regions.
The report covers key developments in the next generation sequencing informatics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from next generation sequencing informatics market are anticipated to have lucrative growth opportunities in the future with the rising demand for next generation sequencing informatics market in the global market. Below mentioned is the list of few companies engaged in the next generation sequencing informatics market.
The report also includes the profiles of key next generation sequencing informatics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Next-generation DNA sequencing (NGS) technology is widely used in a variety of research applications like gene expression, metagenomics, epigenetics, and others. DNA sequencing generates a large volume of data, and analyzing such data can be tedious. Next-generation sequencing informatics tools smooth the process of analyzing sequencing data, thus allowing the scientists to spend more time on research and less time configuring workflows.
MARKET DYNAMICS
The next generation sequencing informatics market is anticipated to grow in the forecast growing adoption of NGS in research and development, constant innovation and developments in the NGS technology and rising demand for tools required for analyzing sequencing data. In addition, untapped market opportunities in emerging nations is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Next generation sequencing informatics market Analysis to 2028" is a specialized and in-depth study of the Healthcare IT industry with a special focus on the global market trend analysis. The report aims to provide an overview of next generation sequencing informatics market with detailed market segmentation by product and services, application, and end user and geography. The next generation sequencing informatics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading next generation sequencing informatics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The next generation sequencing informatics market is segmented on the basis of product and services, application and end user. Based on product and services the market is segmented as NGS informatics services, data analysis & management tool, and primary & secondary data analysis tools. The application segment is divided into drug discovery, genetic screening, diseases diagnosis, precision medicine, and other applications. The technique market is divided into epicardial pacing, transvenous pacing, and transcutaneous pacing. On the basis of end user the market is segmented into hospitals and clinics, academics and research institutes, and pharmaceuticals companies.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the next generation sequencing informatics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The next generation sequencing informatics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting next generation sequencing informatics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the next generation sequencing informatics market in these regions.
The report covers key developments in the next generation sequencing informatics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from next generation sequencing informatics market are anticipated to have lucrative growth opportunities in the future with the rising demand for next generation sequencing informatics market in the global market. Below mentioned is the list of few companies engaged in the next generation sequencing informatics market.
The report also includes the profiles of key next generation sequencing informatics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Agilent Technologies Inc.
- Dnanexus Inc.
- F. Hoffmann-La Roche Ltd
- Intrexon Bioinformatics Germany GmbH (Genomatrix AG)
- llumina Inc.
- Fabric Genomics Inc. (Omicia Inc.)
- Partek Incorporated
- Qiagen NV
- Sapio Sciences
- Thermo Fischer Scientific Inc.